AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |
Back to Blog
Spinal cord stimulator reviews10/30/2022 ![]() Patient benefits include the absence of paresthesias at rest, which can be perceived as uncomfortable, and the lack of supratherapeutic stimulation that can often accompany positional changes with T-SCS. ![]() This results in a predictable and repeatable procedure in which the patient does not need to be awakened from sedation to provide paresthesia coverage feedback. For physicians, no paresthesia mapping is required during placement as leads are placed anatomically. HF10 is a paresthesia-free therapy, which allows for numerous physician and patient benefits. In addition HF10 patients achieved a 68% reduction in opioid usage. Outcomes were further validated in a 1660-patient real-world outcomes publication in which patients reported at 74% responder rate. At 24 months, the responder rate was 76% with a 2.4-cm visual analog scale (VAS) for both back and leg pain. The therapy is backed by robust clinical evidence demonstrating improved and sustained pain relief versus T-SCS through rigorous level I evidence: SENZA-RCT published at 12 and 24 months. HF10 therapy was approved for use in Europe in 2010, Australia in 2011 and the USA in 2015. Nevro was founded in 2006 and introduced 10 kHz SCS with the goal of offering an effective therapy for low-back pain and other chronic pain syndromes. SPINAL CORD STIMULATOR REVIEWS GENERATORThis article provides an overview of HF10 and highlights Nevro’s new Omnia™ implantable pulse generator (IPG) (Nevro Corp., CA, USA). This novel device has been shown to provide superior pain relief and outstanding patient-reported outcomes. While traditional SCS (T-SCS) relies on generation of a paresthesia at the site of pain, HF10 is entirely paresthesia-free. Recent years have seen the creation of new waveforms and variations in electrical dosing, but arguably the most important advancement has been the introduction of high-frequency, 10 kHz SCS (HF10). ![]() Since its inception, the technology has evolved dramatically, and this is particularly evident over the past decade. The use of spinal cord stimulation (SCS) for the treatment of chronic pain was introduced over 50 years ago. The Omnia™ implantable pulse generator is the newest offering in the Senza line and has the ability to provide high-frequency stimulation in addition to multiple other waveforms. ![]() The Senza SCS systems deliver high-frequency stimulation, which has proven superiority over traditional SCS systems for the treatment of back and leg pain. Spinal cord stimulation (SCS) is a well-studied and increasingly used treatment modality for chronic intractable pain states. ![]()
0 Comments
Read More
Leave a Reply. |